Janney Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-106,160
| Closed | -$11.6M | – | 202 |
|
|
2020
Q3 | $11.6M | Sell |
106,160
-8,147
| -7% | -$906K | 0.79% | 40 |
|
|
2020
Q2 | $12.1M | Sell |
114,307
-79,241
| -41% | -$8.18M | 0.83% | 40 |
|
|
2020
Q1 | $17.3M | Sell |
193,548
-26,847
| -12% | -$2.53M | 1.32% | 19 |
|
|
2019
Q4 | $22M | Sell |
220,395
-55,504
| -20% | -$5.23M | 1.19% | 24 |
|
|
2019
Q3 | $24.6M | Sell |
275,899
-13,764
| -5% | -$1.19M | 1.37% | 20 |
|
|
2019
Q2 | $23.9M | Sell |
289,663
-10,418
| -3% | -$817K | 1.3% | 24 |
|
|
2019
Q1 | $24.3M | Sell |
300,081
-9,052
| -3% | -$713K | 1.27% | 25 |
|
|
2018
Q4 | $23.5M | Sell |
309,133
-5,838
| -2% | -$456K | 1.27% | 23 |
|
|
2018
Q3 | $24.9M | Sell |
314,971
-7,690
| -2% | -$582K | 1.08% | 26 |
|
|
2018
Q2 | $22.7M | Sell |
322,661
-1,470
| -0.5% | -$106K | 1% | 33 |
|
|
2018
Q1 | $22.7M | Sell |
324,131
-2,252
| -0.7% | -$156K | 0.99% | 31 |
|
|
2017
Q4 | $22.7M | Sell |
326,383
-223
| -0.1% | -$15K | 0.97% | 32 |
|
|
2017
Q3 | $22.1M | Sell |
326,606
-7,239
| -2% | -$457K | 0.95% | 33 |
|
|
2017
Q2 | $22.8M | Sell |
333,845
-7,266
| -2% | -$474K | 1.07% | 26 |
|
|
2017
Q1 | $21.2M | Sell |
341,111
-6,194
| -2% | -$361K | 0.98% | 33 |
|
|
2016
Q4 | $19M | Sell |
347,305
-19,802
| -5% | -$1.12M | 0.87% | 40 |
|
|
2016
Q3 | $24.1M | Buy |
367,107
+20,929
| +6% | +$1.37M | 1.09% | 31 |
|
|
2016
Q2 | $20.9M | Buy |
346,178
+301
| +0.1% | +$17.5K | 1.11% | 31 |
|
|
2016
Q1 | $19.5M | Buy |
345,877
+6,075
| +2% | +$365K | 1.05% | 38 |
|
|
2015
Q4 | $23.1M | Sell |
339,802
-6,573
| -2% | -$431K | 1.02% | 34 |
|
|
2015
Q3 | $22M | Buy |
+346,375
| New | +$22.8M | 1% | 35 |
|
|
2015
Q2 | – | Sell |
-344,297
| Closed | -$23.6M | – | 79 |
|
|
2015
Q1 | $23.6M | Buy |
344,297
+7,200
| +2% | +$500K | 0.79% | 40 |
|
|
2014
Q4 | $23.7M | Buy |
337,097
+15,122
| +5% | +$1.08M | 1.37% | 17 |
|
|
2014
Q3 | $23M | Buy |
321,975
+20,683
| +7% | +$1.51M | 1.39% | 12 |
|
|
2014
Q2 | $22.4M | Buy |
301,292
+20,623
| +7% | +$1.49M | 1.35% | 13 |
|
|
2014
Q1 | $18.2M | Buy |
280,669
+24,242
| +9% | +$1.57M | 1.21% | 18 |
|
|
2013
Q4 | $15.2M | Buy |
256,427
+29,871
| +13% | +$1.62M | 1.13% | 28 |
|
|
2013
Q3 | $11.8M | Buy |
226,556
+21,821
| +11% | +$1.1M | 0.96% | 34 |
|
|
2013
Q2 | $9.68M | Buy |
+204,735
| New | +$10.4M | 0.95% | 46 |
|
Other funds holding AZN
Janney Capital Management's AZN Position: Q4 2020 in Review
Janney Capital Management sold out of AstraZeneca (AZN) in Q4 2020, closing a stake of 106,160 shares — an estimated $11.6M sold.
Janney Capital Management first reported a position in AZN in Q2 2013 and held it in 29 quarters. The position peaked at $24.9M in Q3 2018. 785 funds tracked by Wall St. Rank hold AZN as of Q4 2020.
- Janney Capital Management reported no remaining AstraZeneca position as of Q4 2020 after selling out during the quarter.
- Janney Capital Management sold 106,160 AstraZeneca shares in Q4 2020, an estimated $11.6M.
- Janney Capital Management first reported a position in AstraZeneca in Q2 2013 and held it in 29 quarters.
- Janney Capital Management's AstraZeneca position peaked at $24.9M in Q3 2018.
- 785 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2020.
Based on Janney Capital Management's 13F filing for Q4 2020, filed 25 Jan 2021.